Alternative titles; symbols
ORPHA: 254892; DO: 0111521;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 15q26.1 | Progressive external ophthalmoplegia, autosomal dominant 1 | 157640 | Autosomal dominant | 3 | POLG | 174763 |
A number sign (#) is used with this entry because autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA (mtDNA) deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25.
Autosomal recessive PEOB1 (258450) is also caused by mutation in the POLG gene.
Progressive external ophthalmoplegia is characterized by multiple mitochondrial DNA deletions in skeletal muscle. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Both autosomal dominant and autosomal recessive inheritance can occur; autosomal recessive inheritance is usually more severe (Filosto et al., 2003; Luoma et al., 2004).
Genetic Heterogeneity of Autosomal Dominant Progressive External Ophthalmoplegia with DNA Deletions
See also PEOA2 (609283), caused by mutation in the ANT1 gene (SLC25A4; 103220) on chromosome 4q34; PEOA3 (609286), caused by mutation in the TWNK (C10ORF2) gene (606075) on chromosome 10q24; PEOA4 (610131), caused by mutation in the POLG2 gene (604983) on chromosome 17q23; PEOA5 (613077), caused by mutation in the RRM2B gene (604712) on chromosome 8q23; and PEOA6 (615156), caused by mutation in the DNA2 gene (601810) on chromosome 10q21.
Lundberg (1962, 1966, 1973) described a large Swedish kindred in which progressive external ophthalmoplegia was associated with hypogonadism. Melberg et al. (1996) provided follow-up. Hypogonadism included delayed sexual maturation, primary amenorrhea, early menopause, and testicular atrophy. Cataracts, cerebellar ataxia, neuropathy, hypoacusis, pes cavus, tremor, parkinsonism, depression, and mental retardation were other features observed in this family. Muscle biopsy samples from advanced cases showed ragged-red fibers, focal cytochrome c oxidase deficiency, and multiple mitochondrial DNA (mtDNA) deletions by Southern blot analysis. An autosomal dominant mode of inheritance was evident with anticipation in successive generations. Melberg et al. (1996) hypothesized that the nuclear gene causing PEO with hypogonadism may be directly influenced by an expansion of an unstable DNA sequence and that the resulting phenotype is caused by a concerted action with multiple deletions of mtDNA. In additional studies of 16 members of this family, Melberg et al. (1996) showed that the muscular involvement commenced cranially and descended in relation to increasing disease duration. In addition to PEO, patients had dysarthria, dysphonia, limb muscle weakness with wasting, absence of Achilles tendon reflexes, and distal vibration sensory loss. The electromyelogram (EMG) was myopathic in facial and proximal limb muscles.
Ozawa et al. (1988) examined skeletal muscle from a mother and daughter, both with chronic progressive ophthalmoplegia. Southern blot analysis revealed in both patients 2 species of mitochondrial DNA, normal mtDNA and partially deleted mtDNA. Curiously, the size of the deletion was different, being about 2.5 kb in the mother and 5 kb in the daughter. The 2 mutant mtDNAs shared a common deleted region of 1.2 kb. However, both the start and the end of the deletion were different, implying a novel mode of inheritance.
Melberg et al. (1998) reported the case of a 57-year-old man, a member of the kindred originally reported by Lundberg (1962), who had PEO and multiple mtDNA deletions and who developed acute rhabdomyolysis provoked by alcohol. A repeated alcohol intake resulted in a 57-fold increase in serum myoglobin.
Luoma et al. (2004) found that affected patients in the family reported by Lundberg (1962) developed parkinsonism later in the disease course with rigidity, bradykinesia, tremor, and favorable response to levodopa.
A family reported by Pepin et al. (1980) had adPEO with cataracts as a prominent feature. A grandmother, mother, and son had early-onset cataracts, and documented mitochondrial myopathy was present in the 2 older family members. The grandmother, aged 62 years, had severe progressive ophthalmoplegia associated with facial, pharyngeal, and limb muscle involvement, as well as premature ovarian failure. Bilateral cataracts, present from at least age 20 years, were removed at age 40. Muscle biopsy showed ragged-red fibers with abnormal mitochondria. Bilateral cataracts were removed in the daughter at age 32. She had mild facial weakness. Despite the absence of ophthalmoplegia, mitochondrial abnormalities were demonstrated in the inferior oblique muscle. The son, clinically healthy at age 10, had had bilateral cataract extraction at age 3 years. The authors cited another family with mitochondrial myopathy involving type I muscle fibers associated with cataract inherited in an apparently autosomal dominant pattern. They also referred to a family with congenital cataract and myocardial and skeletal myopathy of mitochondrial type, also known as Senger syndrome (212350); in that instance, inheritance was thought to be autosomal recessive. All 3 affected persons in the family of Pepin et al. (1980) had the HLA A2-B21 haplotype.
Zeviani et al. (1989) and Servidei et al. (1991) reported an Italian family in which 9 persons in 4 sibships spanning 3 generations were affected by an adult-onset mitochondrial myopathy with multiple mtDNA deletions. Inheritance was autosomal dominant with instances of male-to-male transmission. The main clinical features included progressive external ophthalmoplegia, dysphagia, lactic acidosis, exercise intolerance, and cataracts. Age at onset ranged from 24 to 30 years. Muscle biopsies showed ragged-red fibers and decreased activity of cytochrome c oxidase. Southern blot analysis and PCR showed multiple mtDNA deletions in skeletal muscle of all affected family members, but not in lymphocytes or fibroblasts. The mtDNA deletions appeared to increase with time and correlated with disease severity.
Zeviani et al. (1990) reported 2 additional affected families with mtDNA deletions. Clinical features included adult-onset PEO, proximal muscle weakness and wasting, sensorineural hypoacusis, and cataracts in older patients. Affected members of 1 pedigree also showed tremor, ataxia, and chronic axonal sensorimotor peripheral neuropathy. Muscle biopsy showed ragged-red fibers and decreased cytochrome c oxidase activity. The same portion of mtDNA was involved in all patients. Sequence analysis, performed after mtDNA amplification by PCR, showed that all the deletions started within a 12-nucleotide stretch at the 5-prime end of the D-loop region, a site of active communication between the nucleus and the mtDNA. The authors suggested that a mutation in a nuclear-encoded protein could destroy the integrity of the mitochondrial genome in a specific, heritable way, and that there may be other examples of 'human pathology of...factors involved in the 'cross-talk' between the nuclear and the mitochondrial genomes.'
The existence of a nuclear-encoded factor responsible for mitochondrial deletions or a failure of repair was suggested also by Cormier et al. (1991) for the findings in a family with various mtDNA deletions. The proband had ataxia and episodic ketoacidotic coma. Muscle biopsy showed a mitochondrial myopathy with ragged-red fibers. Various mtDNA deletions were detected not only in the proband but also in his healthy mother and maternal aunt, but not in the other progeny of the mother. All of the deletions were located between the Cox II and cytochrome b genes.
Van Goethem et al. (1997) identified 3 Belgian families with PEO and multiple mitochondrial deletions. The diagnosis was based on clinical symptoms of PEO and muscle weakness, the presence of ragged-red fibers, and multiple mitochondrial deletions in muscle biopsies. Electron microscopy showed subsarcolemmal accumulation of abnormally structured mitochondria with paracrystalline inclusions. The inheritance pattern in 1 family was autosomal dominant, whereas the other 2 families likely had autosomal recessive inheritance.
Chalmers et al. (1996) reported 2 British families with adPEO with additional unusual features, including parkinsonism and pigmentary retinopathy. The parkinsonism was levodopa-responsive. Luoma et al. (2004) reported 7 unrelated families with PEO caused by mutation in the POLG gene; 1 of the families had been reported by Chalmers et al. (1996) and another had been reported by Lundberg (1962). Four families showed definitive autosomal dominant inheritance, 1 showed possible autosomal recessive inheritance, and 2 were undetermined. In 5 families, including the 1 with possible autosomal recessive inheritance, affected members had parkinsonism, with resting tremor, rigidity, bradykinesia, and favorable response to levodopa. Parkinsonism occurred after onset of PEO. Additional features in these families included cataracts, sensory axonal neuropathy, depression, and hypogonadism.
Mancuso et al. (2004) reported 2 sibs with early-onset parkinsonism and a heterozygous mutation in the POLG gene (174763.0015). The proband was a 49-year-old woman with PEO, exercise intolerance, sensory neuropathy, parkinsonism, and gonadal dysgenesis. Skeletal muscle biopsy showed multiple mtDNA deletions. Her brother developed parkinsonism in his early forties. Several other family members reportedly had PEO and exercise intolerance. Mancuso et al. (2004) concluded that parkinsonism may be a prominent feature in patients with POLG mutations, and suggested that mitochondrial dysfunction may play a role in the development of parkinsonism.
In the Swedish kindred with PEO and hypogonadism originally reported by Lundberg (1962), Melberg et al. (1996) excluded linkage of the disorder to the PEO region on chromosome 10q23.3-q24.3 linked to the disease in a Finnish family by Suomalainen et al. (1995); see 609286.
In a Belgian family with adPEO, Van Goethem et al. (2001) found linkage to chromosome 15q22-q26 (maximum 2-point lod score of 3.72 at marker D15S127).
The transmission pattern of progressive external ophthalmoplegia in the family reported by Van Goethem et al. (2001) was consistent with autosomal dominant inheritance.
In affected members of a Belgian pedigree with adPEO, Van Goethem et al. (2001) identified a heterozygous mutation in the POLG gene (Y955C; 174763.0001). In affected members of 5 families with adPEO, Lamantea et al. (2002) identified the heterozygous Y955C mutation. Four families were Italian and 1 was from Greece; 1 of the Italian families was originally reported by Zeviani et al. (1989) and Servidei et al. (1991). In affected members of 5 adPEO families, including the Swedish family originally reported by Lundberg (1962), Luoma et al. (2004) identified the heterozygous Y955C POLG mutation. Affected members of 3 of the families also showed parkinsonism.
Schulte et al. (2009) identified heterozygous POLG mutations in 2 of 26 patients from 23 families with cerebellar ataxia plus external ophthalmoplegia and/or sensory neuropathy. Nine additional patients from this cohort had homozygous or compound heterozygous POLG mutations, consistent with SANDO. Noting that the molecular diagnosis of cerebellar ataxia can be difficult, Schulte et al. (2009) found that for POLG-associated ataxia, the additional presence of ophthalmoplegia had a predictive value of 80%, whereas the presence of neuropathy had a predictive value of 45%.
Associations Pending Confirmation
For discussion of a possible association between adPEO and mutation in the GMPR gene, see 139265.
For discussion of a possible association between adPEO and mutation in the RRM1 gene, see 180410.
Hirano and DiMauro (2001) reviewed the molecular genetics of progressive external ophthalmoplegia and classified the specific disease type according to mutation in the autosomal ANT1, C10ORF2, and POLG genes as well as in multiple mitochondrial genes.
Lamantea et al. (2002) stated that mutations in the ANT1 and C10ORF2 gene account for approximately 4% and 35% of familial adPEO cases, respectively. Mutations in the POLG gene are the most frequent cause of all forms of familial PEO, accounting for approximately 45% of cases.
Lamantea et al. (2002) identified POLG mutations in 10 adPEO families and noted that the clinical features of these patients were often more severe and complex than those associated with ANT1 or C10ORF2 mutations. In particular, patients with POLG mutations also had profound muscle weakness and wasting, severe dysphagia, dysphonia, facial diplegia, ataxia due to distal neurogenic weakness, and severe depression. Lamantea et al. (2002) suggested that the mutant nuclear factor in adPEO may cause a pathologic amplification of the otherwise normal phenomenon of accumulation of mtDNA deletions associated with aging.
Luoma et al. (2004) noted that dominant POLG mutations tend to cluster in the polymerase 'pol' domain of the protein, whereas recessive POLG mutations tend to affect the proofreading exonuclease 'exo' domain. The authors noted the cosegregation of parkinsonism and mutations in the pol domain of the protein, and suggested that mtDNA deletions may play a role in the development of parkinsonism by fostering the accumulation of mtDNA mutations. Mitochondrial DNA deletions may lead to reduced ATP production or oxidative stress, resulting in neurodegeneration.
In a retrospective analysis of 89 patients with mitochondrial progressive external ophthalmoplegia, Rodriguez-Lopez et al. (2020) found that large-scale mtDNA deletion was the most frequent finding (63%), followed by mutations in TWNK, POLG, TK2, and RRM2B.
Holt et al. (1988) found the first example of abnormalities of mitochondrial DNA. When muscle mtDNA was studied, 9 of 25 patients were found to have 2 populations of muscle mtDNA, 1 of which had deletions of up to 7 kilobases. These observations demonstrated that mtDNA heteroplasmy can occur in man and that human disease may be associated with defects of the mitochondrial genome. Only 1 of the patients had an affected relative, a niece who was unavailable for study. It is probable that the deletions in the others arose during oogenesis and that random partitioning of the 2 populations of mtDNA occurred during fetal development. The survival of the deleted mtDNA molecules in muscle is compatible with the observation that the number of muscle fibers does not increase significantly after early fetal life. On the other hand, frequent cell division in leukocyte precursors could select against the survival of cells containing genetically defective mitochondria.
Harding et al. (1988) found that among 71 cases with histologically defined mitochondrial myopathy (ragged-red fibers seen with the modified Gomori trichrome stain), 13 (18%) had relatives who were definitely affected with a similar disorder. Eight familial cases from 4 families were confined to a single generation. In 5 families maternal transmission to offspring occurred. There were no instances of paternal transmission, but 1 patient had an affected cousin in the paternal line. No consistent clinical syndrome or pattern of inheritance emerged for any identified defect of the mitochondrial respiratory chain, localized biochemically in 39 of 41 cases: in complex I (NADH-ubiquinone oxidoreductase) in 26 cases; in complex III (ubiquinol-cytochrome c reductase) in 9 cases; in complex III and complex IV in 1; and in complex V (mitochondrial ATPase) in 1. In 2 patients, oxygen uptake rates were reduced with all substrates tested; in 2 others, in vitro studies of mitochondrial metabolism were normal. Overall, the recurrence rate was 3% for sibs and 5.5% for offspring of index cases. A review of published reports of familial cases of mitochondrial myopathy indicated that the ratio of maternal to paternal transmission is about 9:1.
Chalmers, R. M., Brockington, M., Howard, R. S., Lecky, B. R. F., Morgan-Hughes, J. A., Harding, A. E. Mitochondrial encephalopathy with multiple mitochondrial DNA deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features. J. Neurol. Sci. 143: 41-45, 1996. [PubMed: 8981296] [Full Text: https://doi.org/10.1016/s0022-510x(96)00032-9]
Cormier, V., Rotig, A., Tardieu, M., Colonna, M., Saudubray, J.-M., Munnich, A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am. J. Hum. Genet. 48: 643-648, 1991. [PubMed: 2014791]
Filosto, M., Mancuso, M., Nishigaki, Y., Pancrudo, J., Harati, Y., Gooch, C., Mankodi, A., Bayne, L., Bonilla, E., Shanske, S., Hirano, M., DiMauro, S. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase-gamma. Arch. Neurol. 60: 1279-1284, 2003. [PubMed: 12975295] [Full Text: https://doi.org/10.1001/archneur.60.9.1279]
Harding, A. E., Petty, R. K. H., Morgan-Hughes, J. A. Mitochondrial myopathy: a genetic study of 71 cases. J. Med. Genet. 25: 528-535, 1988. [PubMed: 3050098] [Full Text: https://doi.org/10.1136/jmg.25.8.528]
Hirano, M., DiMauro, S. ANT1, twinkle, POLG, and TP: new genes open our eyes to ophthalmoplegia. Neurology 57: 2163-2165, 2001. [PubMed: 11756592] [Full Text: https://doi.org/10.1212/wnl.57.12.2163]
Holt, I. J., Harding, A. E., Morgan-Hughes, J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717-719, 1988. [PubMed: 2830540] [Full Text: https://doi.org/10.1038/331717a0]
Lamantea, E., Tiranti, V., Bordoni, A., Toscano, A., Bono, F., Servidei, S., Papadimitriou, A., Spelbrink, H., Silvestri, L., Casari, G., Comi, G. P., Zeviani, M. Mutations of mitochondrial DNA polymerase gamma-A are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann. Neurol. 52: 211-219, 2002. [PubMed: 12210792] [Full Text: https://doi.org/10.1002/ana.10278]
Lundberg, P. O. Ocular myopathy with hypogonadism. Acta Neurol. Scand. 38: 142-155, 1962. [PubMed: 14467368] [Full Text: https://doi.org/10.1111/j.1600-0404.1962.tb01084.x]
Lundberg, P. O. Observations on endocrine function in ocular myopathy. Acta Neurol. Scand. 42: 39-61, 1966.
Lundberg, P. O. Hereditary myopathy, oligophrenia, cataract, skeletal abnormalities and hypergonadotropic hypogonadism: a new syndrome. Europ. Neurol 10: 261-280, 1973. [PubMed: 4789103] [Full Text: https://doi.org/10.1159/000114282]
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., Somer, H., Suomalainen, A. Parkinsonism, premature menopause, and mitochondrial DNA polymerase-gamma mutations: clinical and molecular genetic study. Lancet 364: 875-882, 2004. [PubMed: 15351195] [Full Text: https://doi.org/10.1016/S0140-6736(04)16983-3]
Mancuso, M., Filosto, M., Oh, S. J., DiMauro, S. A novel polymerase-gamma mutation in a family with ophthalmoplegia, neuropathy, and parkinsonism. Arch. Neurol. 61: 1777-1779, 2004. [PubMed: 15534189] [Full Text: https://doi.org/10.1001/archneur.61.11.1777]
Melberg, A., Arnell, H., Dahl, N., Stalberg, E., Raininko, R., Oldfors, A., Bakall, B., Lundberg, P. O., Holme, E. Anticipation of autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve 19: 1561-1569, 1996. [PubMed: 8941270] [Full Text: https://doi.org/10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8]
Melberg, A., Holme, E., Oldfors, A., Lundberg, P. O. Rhabdomyolysis in autosomal dominant progressive external ophthalmoplegia. Neurology 50: 299-300, 1998. [PubMed: 9443501] [Full Text: https://doi.org/10.1212/wnl.50.1.299]
Melberg, A., Lundberg, P. O., Henriksson, K. G., Olsson, Y., Stalberg, E. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve 19: 751-757, 1996. [PubMed: 8609926] [Full Text: https://doi.org/10.1002/(SICI)1097-4598(199606)19:6<751::AID-MUS10>3.0.CO;2-O]
Ozawa, T., Yoneda, M., Tanaka, M., Ohno, K., Sato, W., Suzuki, H., Nishikimi, M., Yamamoto, M., Nonaka, I., Horai, S. Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy. Biochem. Biophys. Res. Commun. 154: 1240-1247, 1988. [PubMed: 2841928] [Full Text: https://doi.org/10.1016/0006-291x(88)90272-0]
Pepin, B., Mikol, J., Goldstein, B., Aron, J. J., Lebuisson, D. A. Familial mitochondrial myopathy with cataract. J. Neurol. Sci. 45: 191-203, 1980. [PubMed: 7365499] [Full Text: https://doi.org/10.1016/0022-510x(80)90165-3]
Rodriguez-Lopez, D., Garcia-Cardaba, L. M., Blazquez, A., Serrano-Lorenzo, P., Gutierrez-Gutierrez, G., San Millan-Tejado, B., Muelas, N., Hernandez-Lain, A., Vilchez, J. J., Gutierrez-Rivas, E., Arenas, J., Martin, M. A., Dominguez, C. Clinical, pathological and genetic spectrum n 89 cases of mitochondrial progressive external ophthalmoplegia. J. Med. Genet. 57: 643-646, 2020. [PubMed: 32161153] [Full Text: https://doi.org/10.1136/jmedgenet-2019-106649]
Schulte, C., Synofzik, M., Gasser, T., Schols, L. Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations. Neurology 73: 898-900, 2009. [PubMed: 19752458] [Full Text: https://doi.org/10.1212/WNL.0b013e3181b78488]
Servidei, S., Zeviani, M., Manfredi, G., Ricci, E., Silvestri, G., Bertini, E., Gellera, C., DiMauro, S., DiDonato, S., Tonali, P. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic and biochemical studies. Neurology 41: 1053-1059, 1991. [PubMed: 2067633] [Full Text: https://doi.org/10.1212/wnl.41.7.1053]
Suomalainen, A., Kaukonen, J., Amati, P., Timonen, R., Haltia, M., Weissenbach, J., Zeviani, M., Somer, H., Peltonen, L. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet. 9: 146-151, 1995. [PubMed: 7719341] [Full Text: https://doi.org/10.1038/ng0295-146]
Van Goethem, G., Dermaut, B., Lofgren, A., Martin, J.-J., Van Broeckhoven, C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nature Genet. 28: 211-212, 2001. [PubMed: 11431686] [Full Text: https://doi.org/10.1038/90034]
Van Goethem, G., Martin, J.-J., Lofgren, A., Dehaene, I., Tack, P., Van Zandycke, M., Ververken, D., Ceuterick, C., Van Broeckhoven, C. Unusual presentation and clinical variability in Belgian pedigrees with progressive external ophthalmoplegia and multiple deletions of mitochondrial DNA. Europ. J. Neurol. 4: 476-484, 1997.
Zeviani, M., Bresolin, N., Gellera, C., Bordoni, A., Pannacci, M., Amati, P., Moggio, M., Servidei, S., Scarlato, G., DiDonato, S. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am. J. Hum. Genet. 47: 904-914, 1990. [PubMed: 1978558]
Zeviani, M., Servidei, S., Gellera, C., Bertini, E., DiMauro, S., DiDonato, S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339: 309-311, 1989. [PubMed: 2725645] [Full Text: https://doi.org/10.1038/339309a0]